# Clinical Comparison of Efficacy and Safety of Two Teriparatide Formulations: Osteofortil and Forteo

> **NCT01945788** · PHASE4 · UNKNOWN · sponsor: **Bio Sidus SA** · enrollment: 110 (estimated)

## Conditions studied

- Postmenopausal Osteoporosis With Pathological Fracture

## Interventions

- **DRUG:** Teriparatide (rDNA origin)

## Key facts

- **NCT ID:** NCT01945788
- **Lead sponsor:** Bio Sidus SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-06
- **Primary completion:** 2014-10
- **Final completion:** 2014-11
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2014-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01945788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01945788, "Clinical Comparison of Efficacy and Safety of Two Teriparatide Formulations: Osteofortil and Forteo". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01945788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*